Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - WEHRWEIN SVEN
Last Updated 
27-May-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

WEHRWEIN SVEN: Declared Holdings
Company/RelationshipReportedShares  Ownership
Cogentix Medical, Inc.
Director
NasdaqCM:CGNT
(historical quotes, profile, SEC, other insiders)
31-Jul-1553,998  Direct
Proto Labs, Inc. Common stock
Director
NYSE:PRLB
(historical quotes, profile, other insiders)
20-May-1510,563  Direct
SPS Commerce, Inc.
Director
NasdaqGS:SPSC
(historical quotes, profile, other insiders)
26-Feb-152,895  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
31-Jul-15 22,300CGNT Acquisition (Non Open Market) at $0 per share.
20-May-15 715PRLB Acquisition (Non Open Market) at $0 per share.
31-Mar-15 31,698CGNT Statement of Ownership
26-Feb-15 2,000SPSC Sale at $70 - $70 per share.
(Proceeds of about $140,000)
26-Feb-15 2,000SPSC Option Exercise at $3.03 - $3.03 per share.
(Cost of about $6,060)
25-Feb-15 2,000SPSC Sale at $68 - $68 per share.
(Proceeds of about $136,000)
25-Feb-15 2,000SPSC Option Exercise at $3.03 - $3.03 per share.
(Cost of about $6,060)
6-Jun-14 1,000SPSC Sale at $59.62 - $59.62 per share.
(Proceeds of about $60,000)
6-Jun-14 1,000SPSC Option Exercise at $3.03 - $3.03 per share.
(Cost of about $3,030)

 


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?